Shares of BELLUS Health Inc (TSE:BLU) passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $6.20 and traded as high as $9.57. BELLUS Health shares last traded at $9.57, with a volume of 15,959 shares trading hands.
Separately, Bloom Burton reaffirmed a “buy” rating on shares of BELLUS Health in a report on Thursday, August 1st.
The firm’s fifty day moving average price is C$6.33 and its 200 day moving average price is C$2.94. The firm has a market capitalization of $422.05 million and a PE ratio of -20.64. The company has a current ratio of 6.11, a quick ratio of 6.04 and a debt-to-equity ratio of 0.56.
BELLUS Health Company Profile (TSE:BLU)
BELLUS Health Inc, a clinical-stage biopharmaceutical company, develops novel therapeutics for conditions with high unmet medical need. Its lead drug candidate includes BLU-5937, a small molecule antagonist of the P2X3 receptor for chronic cough. The company also has economic interests in various partnered development stage programs, including KIACTA for the treatment of sarcoidosis; AMO-01 for treatment of Phelan McDermid syndrome; and ALZ-801 for APOE4 homozygous Alzheimer's disease.
Further Reading: S&P 500 Index
Receive News & Ratings for BELLUS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BELLUS Health and related companies with MarketBeat.com's FREE daily email newsletter.